Since a reduction in overall C9orf72 expression from the Rd allele can contribute to the C9-ALS/FTD disease [27–29], a complementary non-mutated allele with increased C9orf72 expression might be beneficial to patients, when the Rd allele is strongly repressed. The gene discussed is C9; the disease is frontotemporal dementia.